Catalyst Wire Dossier Catalyst Wire Dossier

LNK01004 ointment

· Lynk Pharmaceuticals Co., Ltd
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LNK01004 ointment, covering 2024-08-14 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis [Phase 2]

See pricing